KORU PHARMA AVALON GRAND PLUS FILLER
R 1,500.00
KORU PHARMA AVALON GRAND PLUS FILLER (1 box / 1 syringe x 1 ml + 2 needles)
Indications of use
Deep wrinkles
Aesthetic defects in zygomatic and mandibular areas
Volume loss in the cheek area
Undefined face oval contours
Undefined chin shape
Asymmetry, aesthetic defects on nose, nose tip
Benefits
- Developed with MCO™ Tech. purification technology
- Painless and safe procedure
- Long lasting effect
- Short recovery period
- Contains an anaesthetic
- Optimal concentration of HA
- Even distribution of product under the skin
- Correction of moderate to severe facial wrinkles and folds
- Restoring volume and contouring of the face shape
AVALON™ Grand Plus specifications
AVALON™ Grand Plus is a non-surgical filler which contains highly-purified hyaluronic acid (24 mg/ml) and lidocaine (0.3%) for anaesthetic effects.
It is designed to be injected into the deep dermis for the correction of moderate to severe facial wrinkles and folds , cheeks, chin augmentation and shaping of the contours of the face and jawline.
The viscous filler, AVALON™ Grand Plus is an ideal solution for the correction of thick skin and deep wrinkles and it is also efficient in restoring volume with results lasting from 12 – 18 months*.
*The duration of effect might vary depending on the individual physical characteristics of the patient, injection method and type of the procedure.
Cross-linked Hyaluronic Acid in AVALON™ Fillers
MCO™ Tech. (Minimising Cross-linking-agent by Optimising reaction Technology) is a technology developed by Koru Pharmaceuticals’ R&D Institute.
The cross-linking agent serves to connect hyaluronic acid chains to form a net.
Through optimisation of cross-linking reaction conditions in which a chemical reaction between the cross-linking agent and HA occurs, the use of the cross-linking agent is minimised, thereby maximising the efficiency of the cross-linking reaction.
